The First Research Agenda For the
Chiropractic Profession in Europe
SOURCE: Chiropractic & Manual Therapies 2014 (Feb 10); 22 (1): 9
Sidney M Rubinstein, Jenni Bolton, Alexandra L Webb,
and Jan Hartvigsen
Department of Health Sciences,
Faculty of Earth and Life Sciences,
VU University, Amsterdam,
1081 HV Amsterdam, The Netherlands.
BACKGROUND: Research involving chiropractors is evolving and expanding in Europe while resources are limited. Therefore, we considered it timely to initiate a research agenda for the chiropractic profession in Europe. The aim was to identify and suggest priorities for future research in order to best channel the available resources and facilitate advancement of the profession.
METHODS: In total, 60 academics and clinicians working in a chiropractic setting, and who had attended any of the annual European Chiropractors’ Union/European Academy of Chiropractic (ECU/EAC) Researchers’ Day meetings since their inception in 2008, were invited to participate. Data collection consisted of the following phases: phase 1 identification of themes; phase 2 consensus, which employed a Delphi process and allowed us to distill the list of research priorities; and phase 3 presentation of the results during both the Researchers’ Day and a plenary session of the annual ECU Convention in May 2013. In addition, results were distributed to all ECU member countries.
RESULTS: The response rate was 42% from phase 1 and 68% from phase 2. In general, participants were middle-aged, male and had been awarded a Doctor of Philosophy (PhD) as well as chiropractic degree. Approximately equal numbers of participants had obtained their chiropractic degree from the UK/Europe and North America. The majority of participants worked primarily in an academic/research environment and approximately half worked in an independent institution. In total, 58% of the participants were from the UK and Denmark, collectively representing 44% of the chiropractors working in Europe. In total, 70 research priorities were identified, of which 19 reached consensus as priorities for future research. The following three items were thought to be most important:
1) cost-effectiveness/economic evaluations,
2) identification of subgroups likely to respond to treatment, and
3) initiation and promotion of collaborative research activities.